Can vitamin D reduce inflammation in relapsing-remitting multiple sclerosis?

Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis

(2015) Egil Røsjø et al.   JOURNAL OF NEUROIMMUNOLOGY

Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis

(2015) Egil Røsjø et al.   JOURNAL OF NEUROLOGY

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

(2015) J Kuhle et al.   Multiple Sclerosis Journal

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b

(2015) Kathryn C. Fitzgerald et al.   JAMA Neurology

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

(2015) J Kuhle et al.   Multiple Sclerosis Journal

Effect of high-dose 1.25 dihydroxyvitamin D3on remyelination in the cuprizone model

(2014) Agnes E. Nystad et al.   APMIS

Increasing serum levels of vitamin A, D and E are associated with alterations of different inflammation markers in patients with multiple sclerosis

(2014) Egil Røsjø et al.   JOURNAL OF NEUROIMMUNOLOGY

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid

(2013) Jorge Correale et al.   JOURNAL OF NEUROIMMUNOLOGY

The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis

(2013) Eleanor James et al.   Multiple Sclerosis Journal

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

(2012) Ellen M. Mowry et al.   ANNALS OF NEUROLOGY

Traditionally living populations in East Africa have a mean serum 25-hydroxyvitamin D concentration of 115 nmol/l

(2012) Martine F. Luxwolda et al.   BRITISH JOURNAL OF NUTRITION

A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis

(2012) Merja Soilu-Hänninen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial

(2012) Margitta T Kampman et al.   Multiple Sclerosis Journal

Vitamin D and disease activity in multiple sclerosis before and during interferon-  treatment

(2012) K. I. Loken-Amsrud et al.   NEUROLOGY

Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis

(2011) Stephanie Knippenberg et al.   Multiple Sclerosis Journal

Low bone mass in newly diagnosed multiple sclerosis and clinically isolated syndrome

(2011) S. M. Moen et al.   NEUROLOGY

Vitamin D and multiple sclerosis

(2010) Alberto Ascherio et al.   LANCET NEUROLOGY